We're excited to announce some new additions to the 2024 STAT Summit lineup. Over the next six weeks, STAT's Editorial Events team will be building on this list of powerful names taking the stage in Boston this October. More announcements coming soon...
Don't miss your chance to connect with C-suite leaders, innovators, investors, and more as we dig into the biggest barriers people face in changing health and medicine, and how they're working to overcome them.
Early Speaker Highlights:
Tony Coles, M.D.
Chairman, Cerevel Therapeutics
D.A. Wallach
VC Investor and Recording Artist
Yvonne Greenstreet
CEO, Alnylam Pharmaceuticals
Tickets are limited — Register now to secure your spot!
General Admission and Agency & Sales passes are extremely limited. Register now to secure your spot at STAT's annual flagship event.
%20MH%20Testing/Larger%20Header%20Logos/STAT_Events2.png?height=88&upscale=true&name=STAT_Events2.png){kind=small}
.jpg?width=1200&upscale=true&name=Flagship2024%20Sponsor%20Email%20(1).jpg)
No comments